KKR acquired Healthium Medtech Ltd., a leading Indian medical devices company, from Apax Partners. The deal, valued at approximately Rs 7000 crore, involves a special purpose vehicle owned by KKR-managed funds gaining control of Healthium. Healthium, the fourth-largest surgical suture manufacturer globally, maintains a strong presence in India and abroad, with KKR aiming to leverage its expertise to further expand its reach
KKR and Apax have signed a binding agreement for purchase of the Bengaluru-based company, with a formal announcement expected as early as Monday, the people cited said. Moneycontrol was first to report on Saturday that KKR was the highest bidder for Healthium. Mankind-ChrysCapital had offered ₹6,500 crore ($780 million), said the people cited.
KKR to acquire Healthium Medtech for Rs 7000 crore from Apax Partners. Novo Holdings, Mankind Pharma, and ChrysCapital competed in the bidding. Anish Bafna will continue to lead Healthium under KKR ownership.
KKR, Carlyle, EQT, Hillhouse, and TA Associates are competing to acquire Healthium Medtech, the largest homegrown surgical sutures and surgical needles manufacturer in India. Apax Partners currently owns 99.8% of Healthium. The company has a significant international presence and moderate client concentration risk.